Arkolith/Insider Trading/OMIC/Form 4

Spaventa Andrew

Chief Executive Officer, DirectorSingular Genomics Systems, Inc. (OMIC) · full profile →Form 4 · filed Sep 17, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2K
Net Open-Market Flow
-$2K
Transactions
5
4 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 15, 2024Option exercise(M)487——812
Sep 15, 2024Gift(G)312—$0140K
Sep 15, 2024Gift(G)312—$0325
Sep 15, 2024Sell(S)175$12.38$2K637

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 15, 2024Option exercise(M)487—$05K

Transaction Codes

M
Option exercise / conversion
G
Gift
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-107502) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML